Companion Diagnostics - Global Market Outlook (2015-2022)
According to Stratistics MRC, the Global Companion Diagnostics Market is accounted for $2.62 billion in 2015 and is expected to reach $9.27 billion by 2022 growing at a CAGR of 19.78% during the forecast period. At present, increasing demand for personalized medicine is mostly contributing to the global companion diagnostics market growth. On the other hand, cost allied with developing drugs could hamper the market. Developing companion diagnostics for several central nervous system conditions and hereditary conditions provide ample of opportunities for players in the market.
In terms of revenue, Breast cancer commanded the global companion diagnostics market. However, lung cancer is expected to lead the market in future growing at a significant CAGR owing to the discovery of biomarkers that are precise to lung cancer, and the discovery of myriad pertinent companion diagnostics. Molecular diagnostics is highest revenue generating segment and also expected to grow at a faster rate, mainly owing to the use of techniques such as real time PCR, In Situ Hybridization and next generation sequencing.
North America represented the largest market for companion diagnostics, followed by the Europe. The Asia Pacific and Rest of the World regions are anticipated to witness substantial demand for companion diagnostics in the future. In these regions, enhancing healthcare infrastructure, rising disposable incomes, and unexploited potential for companion diagnostics are cited as the major reasons for the market growth.
Some of the key players in the market include are Roche Diagnostics, Quest Diagnostics Inc.Qiagen N.V., Labcorp, Genomic Health Inc., Dako (Agilent Technologies), Celera, Biomerieux Sa, Abbott Laboratories, Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare, Biogenex Laboratories, Siemens and AstraZeneca.
Technologies Covered:
In terms of revenue, Breast cancer commanded the global companion diagnostics market. However, lung cancer is expected to lead the market in future growing at a significant CAGR owing to the discovery of biomarkers that are precise to lung cancer, and the discovery of myriad pertinent companion diagnostics. Molecular diagnostics is highest revenue generating segment and also expected to grow at a faster rate, mainly owing to the use of techniques such as real time PCR, In Situ Hybridization and next generation sequencing.
North America represented the largest market for companion diagnostics, followed by the Europe. The Asia Pacific and Rest of the World regions are anticipated to witness substantial demand for companion diagnostics in the future. In these regions, enhancing healthcare infrastructure, rising disposable incomes, and unexploited potential for companion diagnostics are cited as the major reasons for the market growth.
Some of the key players in the market include are Roche Diagnostics, Quest Diagnostics Inc.Qiagen N.V., Labcorp, Genomic Health Inc., Dako (Agilent Technologies), Celera, Biomerieux Sa, Abbott Laboratories, Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare, Biogenex Laboratories, Siemens and AstraZeneca.
Technologies Covered:
- Molecular diagnostics
- In Situ Hybridization (ISH)
- CISH
- FISH
- Polymerase Chain Reaction (PCR)
- Next generation sequencing
- Other Technologies
- Immunohistochemistry
- Colorectal Cancer
- Gastric Cancer
- Lung Cancer
- Breast Cancer
- Melanoma
- Other Applications
- Cardiovascular conditions
- Inflammation
- Virology
- Oncology
- Other Indications
- Pharmaceutical Companies
- Reference Lab
- Physicians
- Hospitals
- Academic Medical Centers
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY
5.1 Introduction
5.2 Molecular diagnostics
5.2.1 In Situ Hybridization (ISH)
5.2.1.1 CISH
5.2.1.1.2 FISH
5.2.2 Polymerase Chain Reaction (PCR)
5.2.3 Next generation sequencing
5.2.4 Other Technologies
5.3 Immunohistochemistry
6 GLOBAL COMPANION DIAGNOSTICS MARKET, BY APPLICATION
6.1 Introduction
6.2 Colorectal Cancer
6.3 Gastric Cancer
6.4 Lung Cancer
6.5 Breast Cancer
6.6 Melanoma
6.7 Other Applications
7 GLOBAL COMPANION DIAGNOSTICS MARKET, BY INDICATION
7.1 Introduction
7.2 Cardiovascular conditions
7.3 Inflammation
7.4 Virology
7.5 Oncology
7.6 Other Indications
8 GLOBAL COMPANION DIAGNOSTICS MARKET, BY END USER
8.1 Introduction
8.2 Pharmaceutical Companies
8.3 Reference Lab
8.4 Physicians
8.5 Hospitals
8.6 Academic Medical Centers
9 GLOBAL COMPANION DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 Roche Diagnostics
11.2 Quest Diagnostics Inc.
11.3 Qiagen N.V.
11.4 Labcorp
11.5 Genomic Health Inc.
11.6 Dako (Agilent Technologies)
11.7 Celera
11.8 Biomerieux Sa
11.9 Abbott Laboratories
11.10 Thermo Fisher Scientific, Inc.
11.11 Danaher Corporation
11.12 GE Healthcare
11.13 Biogenex Laboratories
11.14 Siemens
11.15 AstraZeneca
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY
5.1 Introduction
5.2 Molecular diagnostics
5.2.1 In Situ Hybridization (ISH)
5.2.1.1 CISH
5.2.1.1.2 FISH
5.2.2 Polymerase Chain Reaction (PCR)
5.2.3 Next generation sequencing
5.2.4 Other Technologies
5.3 Immunohistochemistry
6 GLOBAL COMPANION DIAGNOSTICS MARKET, BY APPLICATION
6.1 Introduction
6.2 Colorectal Cancer
6.3 Gastric Cancer
6.4 Lung Cancer
6.5 Breast Cancer
6.6 Melanoma
6.7 Other Applications
7 GLOBAL COMPANION DIAGNOSTICS MARKET, BY INDICATION
7.1 Introduction
7.2 Cardiovascular conditions
7.3 Inflammation
7.4 Virology
7.5 Oncology
7.6 Other Indications
8 GLOBAL COMPANION DIAGNOSTICS MARKET, BY END USER
8.1 Introduction
8.2 Pharmaceutical Companies
8.3 Reference Lab
8.4 Physicians
8.5 Hospitals
8.6 Academic Medical Centers
9 GLOBAL COMPANION DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 Roche Diagnostics
11.2 Quest Diagnostics Inc.
11.3 Qiagen N.V.
11.4 Labcorp
11.5 Genomic Health Inc.
11.6 Dako (Agilent Technologies)
11.7 Celera
11.8 Biomerieux Sa
11.9 Abbott Laboratories
11.10 Thermo Fisher Scientific, Inc.
11.11 Danaher Corporation
11.12 GE Healthcare
11.13 Biogenex Laboratories
11.14 Siemens
11.15 AstraZeneca
LIST OF TABLES
Global Companion Diagnostics Market Outlook, By Region (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
1Rest of the World Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Region (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Global Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
North America Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Europe Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Asia Pacific Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Molecular diagnostics (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Next generation sequencing (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Immunohistochemistry (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Application (2013-2022) ($MN)
1Rest of the World Companion Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Gastric Cancer (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Melanoma (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Indication (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Cardiovascular conditions (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Inflammation (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Virology (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Oncology (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Other Indications (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By End User (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Reference Lab (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Physicians (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Rest of the World Companion Diagnostics Market Outlook, By Academic Medical Centers (2013-2022) ($MN)
